Open AccessShort-Course Rifampin and Pyrazinamide Compared with Isoniazid for Latent Tuberculosis Infection: A Cost-Effectiveness Analysis Based on a Multicenter Clinical Trial
Author(s) -
Kashef Ijaz,
Peter D. McElroy,
Thomas R. Navin
Publication year - 2004
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/421783
Subject(s) - medicine , pyrazinamide , isoniazid , short course , tuberculosis , latent tuberculosis , antibacterial agent , rifampicin , clinical trial , antibiotics , mycobacterium tuberculosis , pediatrics , microbiology and biotechnology , pathology , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom